Literature DB >> 20478792

Using alternating bilateral stimulation of eye movement desensitization for treatment of fearful patients.

Dominic P Lu1.   

Abstract

Since the mid-1990s, eye movement desensitization (EMD) has been used in the realm of clinical psychology and psychiatry as a nonpharmacotherapeutic modality for the treatment of phobias, post-traumatic symptoms, and various psychotrauma cases. EMD can also be incorporated into the use of hypnosis, although the two are not the same thing. This study examined various clinical applications of the eye movement component of EMD (known as alternating bilateral stimulation (ABS)) on fearful dental patients who had a history of traumatic dental experiences. Findings were based on the clinical impressions and assessments of both the patients and the operating team. Results show that ABS, while effective for enabling patients to undergo non-invasive dental procedures such as clinical examinations and simple prophylaxis, has only limited beneficial effect for extremely fearful patients who must undergo invasive procedures such as extraction, drilling, and injections. Nevertheless, ABS is effective for mild to moderate patient phobia and anxiety. Although EMD is more effective than ABS, ABS is simple and easy for patients and clinicians to perform during treatment and can be performed readily in the dental office.

Entities:  

Mesh:

Year:  2010        PMID: 20478792

Source DB:  PubMed          Journal:  Gen Dent        ISSN: 0363-6771


  2 in total

1.  Auricular Chromotherapy in the Treatment of Psychologic Trauma, Phobias, and Panic Disorder.

Authors:  Alexandre Massao Yoshizumi; Daniel Guillermo Asis; Fabiola Andrade Luz
Journal:  Med Acupunct       Date:  2018-06-01

2.  Eye Movement Distraction: A New Distraction Technique for Management of Dental Anxiety during Intraoral Local Anesthesia Administration in Children.

Authors:  Sunnypriyatham Tirupathi; Nirmala Krishna; Srinitya Rajasekhar; Sivakumar Nuvvula
Journal:  Int J Clin Pediatr Dent       Date:  2019 Nov-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.